JW Lifescience Corporation (KRX: 234080)

JW Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27,423	20,222	3,920	4,923	2,592	9,861
Short-Term Investments	7,110	8,126	24,953	155.05	-	-
Cash & Short-Term Investments	34,534	28,348	28,873	5,078	2,592	9,861
Cash Growth	2.98%	-1.82%	468.59%	95.88%	-73.71%	-22.82%
Accounts Receivable	57,370	55,505	53,426	32,141	34,716	33,888
Other Receivables	427.62	252.42	346.01	257.79	161.45	131.27
Receivables	59,898	55,757	53,772	37,198	36,578	34,019
Inventory	25,478	23,399	22,067	21,077	16,786	15,777
Prepaid Expenses	318.33	24.78	236.47	1,044	505.8	18.88
Other Current Assets	100.29	305.56	60.7	32.79	34.08	179.91
Total Current Assets	120,329	107,834	105,008	64,430	56,496	59,856
Property, Plant & Equipment	120,285	124,577	131,555	137,145	135,423	131,690
Long-Term Investments	8,647	10,419	4,390	8,934	13,097	518.87
Goodwill	950.99	950.99	950.99	950.99	950.99	950.99
Other Intangible Assets	2,709	2,870	3,100	3,671	3,916	3,834
Long-Term Deferred Tax Assets	14.68	15.81	-	-	-	-
Long-Term Deferred Charges	276.97	305.14	484.8	689.12	893.45	1,147
Other Long-Term Assets	7,179	8,865	7,453	3,646	3,626	3,408
Total Assets	260,391	255,836	252,942	219,467	214,402	201,404
Accounts Payable	19,723	18,740	15,118	12,496	10,714	11,263
Accrued Expenses	1,045	1,271	1,156	724.7	655.62	844.37
Short-Term Debt	15,700	15,700	36,681	44,350	32,000	34,040
Current Portion of Long-Term Debt	336	30,353	336	336	2,817	5,000
Current Portion of Leases	81.58	44.91	131.02	159.77	147.67	200.53
Current Income Taxes Payable	3,201	2,739	3,645	3,279	6,200	3,874
Other Current Liabilities	24,420	25,411	22,976	22,557	16,734	11,649
Total Current Liabilities	64,506	94,259	80,044	83,902	69,268	66,871
Long-Term Debt	30,146	168	30,007	1,610	1,512	5,430
Long-Term Leases	92.2	46.68	40.42	31.91	60.65	37.27
Long-Term Deferred Tax Liabilities	1,927	1,828	2,011	2,243	3,305	4,897
Other Long-Term Liabilities	279.02	141.95	508.07	187.8	7,762	711.2
Total Liabilities	96,950	96,443	112,610	87,975	81,908	78,788
Common Stock	39,586	39,586	39,586	39,586	39,586	39,586
Additional Paid-In Capital	28,335	28,335	28,335	28,335	28,335	28,335
Retained Earnings	102,268	98,220	79,160	70,319	64,572	54,694
Treasury Stock	-6,749	-6,749	-6,749	-6,749	-	-
Comprehensive Income & Other	0	0	0	0	-	-
Shareholders' Equity	163,441	159,393	140,332	131,492	132,494	122,615
Total Liabilities & Equity	260,391	255,836	252,942	219,467	214,402	201,404
Total Debt	46,355	46,313	67,195	46,488	36,537	44,707
Net Cash (Debt)	-11,822	-17,965	-38,322	-41,410	-33,945	-34,846
Net Cash Per Share	-763.46	-1160.20	-2474.87	-2657.82	-2143.72	-2200.64
Filing Date Shares Outstanding	15.48	15.48	15.48	15.48	15.83	15.83
Total Common Shares Outstanding	15.48	15.48	15.48	15.48	15.83	15.83
Working Capital	55,822	13,574	24,965	-19,472	-12,772	-7,015
Book Value Per Share	10555.09	10293.69	9062.74	8491.82	8367.39	7743.54
Tangible Book Value	159,781	155,573	136,281	126,870	127,627	117,831
Tangible Book Value Per Share	10318.73	10046.95	8801.12	8193.30	8060.01	7441.37
Land	32,459	32,459	32,459	32,459	32,459	31,989
Buildings	38,274	39,820	41,648	42,618	44,529	46,781
Machinery	47,877	51,450	56,836	44,976	46,086	45,238
Construction In Progress	1,503	758.47	440.73	16,903	12,143	7,441

Source: S&P Capital IQ. Standard template. Financial Sources.